Upload Avatar (500 x 500)
Hong Yu
yu.hong@whu.edu.cn
Chinese, English, French
Hubei
Wuhan University
Basic Medical Sciences
  • 1987-1992 Bachelor of Medicine: Wuhan University Medical School (formerly Hubei Medical University)
  • 1994-1999 Doctor of Medicine: Wuhan University Medical School, Cardiovascular Internal Medicine
  • 2001-2002 Postdoctoral Research: Nancy 1 University, France
  • 2003-2005 Postdoctoral Research: Vanderbilt University Medical Center, Cardiovascular Medicine
  • 1992-1997 Assistant, Department of Biochemistry, Wuhan University Medical School
  • 1997-2000 Lecturer, Department of Biochemistry, Wuhan University Medical School
  • 2000-2005 Associate Professor, Department of Biochemistry and Molecular Biology, Wuhan University Medical School
  • 2005-2008 Professor, Associate Director, Department of Biochemistry and Molecular Biology, Wuhan University
  • 2008-2013 Professor, Associate Director, Department of Biochemistry and Molecular Biology, Wuhan University
  • 2013-Present Professor, Director, Department of Biochemistry and Molecular Biology, Wuhan University
  • 2016 Advanced Female Faculty of Wuhan University
  • 2016 Third Prize, 16th Hubei Province Natural Science Excellent Academic Paper
  • 2017 Second Outstanding Teaching Performance Award, Wuhan University
  • 2018 Special Prize, First International Symposium on Cholesterol Reverse Transport
  • 2020 Second Prize, Fifth National College Student Life Science Innovation and Entrepreneurship Competition (as mentor)
Molecular mechanisms and prevention of atherosclerosis
Biotechnology and pharmaceutical research
  • Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice, Yu H*, 2020
  • Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice, Yu H*, 2018
  • Isoliquiritigenin attenuates atherogenesis in apolipoprotein E deficient mice, Yu H*, 2016
  • A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice, Yu H*, 2016
  • Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice, Yu H*, 2015
  • PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice, Yu H*, 2015
  • Effect of the apolipoprotein E mimetic peptide EpK on atherosclerosis in apoE-/- mice, Yu H*, 2015
Atherosclerosis Molecular Mechanisms Prevention Biotechnology Pharmaceutical Research Metabolic Diseases Cardiovascular Diseases Gene Engineering Antioxidants Biological Peptides

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.